"We expect to build an exciting portfolio of leading biotechnology companies from cutting-edge European science."
"The hands-on approach to building companies really appeals to the scientist in me. And we are translating discoveries in the laboratory into novel medicines."
"Scaling up early-stage companies from academic concepts to industrial development provides a great sense of accomplishment."
"Working with researchers to create new start-ups is personally very rewarding, because you're helping to move promising science into the real world, where patients benefit."
Gabriella Camboni
Partner, Sofinnova Partners - Biovelocita Strategy
Matthieu Coutet
Partner, Sofinnova Partners - Biovelocita Strategy
Alex Leech
Partner, Sofinnova Partners - Biovelocita Strategy
Zhizhong (Joel) Yao
Partner, Sofinnova Partners - Biovelocita Strategy
Marie Duranteau
Associate, Program Manager, Sofinnova Partners - Biovelocita Strategy
Cristina Pelizon
Associate, Program Manager, Sofinnova Partners - Biovelocita Strategy
Related News